RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

IPCA Laboratories Revenue 2024

IPCA Laboratories Revenue

77.54 B INR

IPCA Laboratories Dividend yield

0.15 %

Ticker

IPCALAB.NS

ISIN

INE571A01038

In 2024, IPCA Laboratories's sales reached 77.54 B INR, a 24.17% difference from the 62.44 B INR sales recorded in the previous year.

The IPCA Laboratories Revenue history

YEARREVENUE (undefined INR)GROSS MARGIN (%)
2026e106.5132,98
2025e92.5337,97
2024e77.5445,31
202362.4456,26
202258.359,16
202154.262,47
202046.4958,27
201937.7360,39
201832.8458,46
201732.1157,29
201629.0755,55
201531.4257,16
201432.8259,99
201328.1355,57
201223.5956,02
20111954,44
201015.639,68
200912.8436,84
200810.5130,05
20079.2832,66
20067.5628,03
20056.7930,15
20046.0628,58

IPCA Laboratories Aktienanalyse

What does IPCA Laboratories do?

IPCA Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding IPCA Laboratories's Sales Figures

The sales figures of IPCA Laboratories originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing IPCA Laboratories’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize IPCA Laboratories's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in IPCA Laboratories’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about IPCA Laboratories Stock

How much revenue did IPCA Laboratories generate this year?

IPCA Laboratories has achieved a revenue of 77.54 B INR this year.

How much was the turnover of the company IPCA Laboratories compared to the previous year?

The revenue of IPCA Laboratories has increased by 24.17% increased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of IPCA Laboratories?

The revenue of IPCA Laboratories is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of IPCA Laboratories measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of IPCA Laboratories so important for investors?

The revenue of IPCA Laboratories is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does IPCA Laboratories pay?

Over the past 12 months, IPCA Laboratories paid a dividend of 2 INR . This corresponds to a dividend yield of about 0.15 %. For the coming 12 months, IPCA Laboratories is expected to pay a dividend of 2.28 INR.

What is the dividend yield of IPCA Laboratories?

The current dividend yield of IPCA Laboratories is 0.15 %.

When does IPCA Laboratories pay dividends?

IPCA Laboratories pays a quarterly dividend. This is distributed in the months of December, December, December, December.

How secure is the dividend of IPCA Laboratories?

IPCA Laboratories paid dividends every year for the past 10 years.

What is the dividend of IPCA Laboratories?

For the upcoming 12 months, dividends amounting to 2.28 INR are expected. This corresponds to a dividend yield of 0.17 %.

In which sector is IPCA Laboratories located?

IPCA Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IPCA Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IPCA Laboratories from 12/5/2023 amounting to 2 INR, you needed to have the stock in your portfolio before the ex-date on 11/22/2023.

When did IPCA Laboratories pay the last dividend?

The last dividend was paid out on 12/5/2023.

What was the dividend of IPCA Laboratories in the year 2023?

In the year 2023, IPCA Laboratories distributed 4 INR as dividends.

In which currency does IPCA Laboratories pay out the dividend?

The dividends of IPCA Laboratories are distributed in INR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von IPCA Laboratories

Our stock analysis for IPCA Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IPCA Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.